Kastora Stavroula, Triantafyllidou Olga, Kounidas Georgios, Vlahos Nikolaos
Acute Medicine, Grampian University Hospitals NHS Trust, Aberdeen, UK
School of Medicine, University of Aberdeen College of Life Sciences & Medicine, Aberdeen, UK.
BMJ Case Rep. 2021 Mar 24;14(3):e241251. doi: 10.1136/bcr-2020-241251.
Fanconi anaemia is a heterogeneous condition associated with mutations in the Fanconi anaemia complementation group (FANC). The FANC group has also been extensively associated with tumourigenesis due to its intricate association with the cellular repair mechanism. In this case report, we are drawing initial associations between a previously unreported FANC-A gene point mutation (P1222L) and familial breast cancer, by examining the presentation and management of a 65-year-old female patient with history of bilateral breast cancer of two different histological categories (ductal and in situ lobular). Here, we present a further genetic analysis beyond the common clinical practice to understand the patient's genetic predisposition and improve their long-term management.
范可尼贫血是一种与范可尼贫血互补组(FANC)基因突变相关的异质性疾病。由于FANC组与细胞修复机制有着复杂的关联,它也与肿瘤发生密切相关。在本病例报告中,我们通过检查一名65岁患有两种不同组织学类型(导管癌和小叶原位癌)双侧乳腺癌病史的女性患者的临床表现和治疗情况,初步探讨了一种先前未报道的FANC-A基因点突变(P1222L)与家族性乳腺癌之间的关联。在此,我们进行了超出常规临床实践的进一步基因分析,以了解患者的遗传易感性并改善其长期治疗。